MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 198 filers reported holding MEDICINES CO in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $13,109,000 | +2537.6% | 154,334 | +1451.7% | 0.50% | +2168.2% |
Q3 2019 | $497,000 | -59.0% | 9,946 | -75.4% | 0.02% | -68.6% |
Q3 2018 | $1,211,000 | -18.7% | 40,500 | -0.2% | 0.07% | -25.5% |
Q2 2018 | $1,490,000 | +13.9% | 40,600 | +2.3% | 0.09% | -1.1% |
Q1 2018 | $1,308,000 | +30.7% | 39,700 | +8.5% | 0.10% | +18.8% |
Q4 2017 | $1,001,000 | +132.8% | 36,600 | +315.9% | 0.08% | +95.1% |
Q1 2017 | $430,000 | +523.2% | 8,800 | +384.0% | 0.04% | +485.7% |
Q3 2016 | $69,000 | -52.7% | 1,818 | -60.5% | 0.01% | -65.0% |
Q1 2016 | $146,000 | +80.2% | 4,601 | +58.7% | 0.02% | +81.8% |
Q1 2015 | $81,000 | +39.7% | 2,900 | +11.5% | 0.01% | +37.5% |
Q3 2014 | $58,000 | -33.3% | 2,600 | -13.3% | 0.01% | -33.3% |
Q2 2014 | $87,000 | +8.8% | 3,000 | +7.1% | 0.01% | +9.1% |
Q1 2014 | $80,000 | +128.6% | 2,800 | +211.1% | 0.01% | +83.3% |
Q4 2013 | $35,000 | -95.0% | 900 | -95.7% | 0.01% | -94.7% |
Q3 2013 | $704,000 | +2507.4% | 21,000 | +2525.0% | 0.11% | +2180.0% |
Q1 2013 | $27,000 | – | 800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,778,742 | $105,616,000 | 23.17% |
Sarissa Capital Management LP | 3,636,000 | $101,626,000 | 15.30% |
BRIDGER MANAGEMENT, LLC | 2,841,761 | $79,427,000 | 6.29% |
HighVista Strategies LLC | 234,340 | $6,550,000 | 5.34% |
Slate Path Capital LP | 2,170,000 | $60,652,000 | 4.91% |
Camber Capital Management LP | 2,471,523 | $69,079,000 | 3.44% |
Antipodean Advisors LLC | 170,000 | $4,752,000 | 3.38% |
Parian Global Management LP | 152,400 | $4,260,000 | 2.96% |
DLD Asset Management, LP | 2,334,800 | $65,258,000 | 2.40% |
Boxer Capital, LLC | 600,000 | $16,770,000 | 1.94% |